Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine-Reference-Cited by-同舟云学术

Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine

Published:2017-10-19 Issue:3 Volume:17 Page:345-349
ISSN:1389-9600
Container-title:Familial Cancer
language:en
Short-container-title:Familial Cancer

Author:

Myszka Aleksander,Nguyen-Dumont Tu,Karpinski Pawel,Sasiadek Maria M.,Akopyan Hayane,Hammet Fleur,Tsimiklis Helen,Park Daniel J.,Pope Bernard J.,Slezak Ryszard,Kitsera Nataliya,Siekierzynska Aleksandra,Southey Melissa C.^ORCID

Funder

National Health and Medical Research Council

VLSCI

European Social Fund, Human Capital, national Cohesion Strategy

National Breast Cancer Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics (clinical),Oncology,Genetics

Link

http://link.springer.com/article/10.1007/s10689-017-0050-6/fulltext.html

Reference19 articles.

1. Southey MC, Winship I, Nguyen-Dumont T (2016) PALB2: research reaching to clinical outcomes for women with breast cancer. Hered Cancer Clin Pract 14:9. doi: 10.1186/s13053-016-0049-2

2. Antoniou A, Pharoah PDP, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130

3. Antoniou AC, Casadei S, Heikkinen T et al (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371(6):497–506. doi: 10.1056/NEJMoa1400382

4. Southey MC, Goldgar DE, Winqvist R et al (2016) PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet. doi: 10.1136/jmedgenet-2016-103839

5. Cybulski C, Kluzniak W, Huzarski T et al (2015) Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis. Lancet Oncol 16(6):638–644. doi: 10.1016/S1470-2045(15)70142-7

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis.;Gynecologic Oncology;2023-10

2. Clinical Significance of Gene Mutations and Polymorphic Variants and their Association with Prostate Cancer Risk in Polish Men;Cancer Control;2022-01

3. PALB2 Variants: Protein Domains and Cancer Susceptibility;Trends in Cancer;2021-03

4. Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer?;Genetics Research;2020

5. Hi-Plex2: a simple and robust approach to targeted sequencing-based genetic screening;BioTechniques;2019-09